Back to Agenda
Roundtable Discussions
Session Chair(s)
Representative Invited
DIA, Switzerland
Each day’s networking luncheon offers both open seating and focused roundtable discussions. Each topic listed below will be hosted at a designated table led by a moderator. If you’re passionate about one of these subjects or would like to exchange ideas with peers who share similar interests, we invite you to join a designated table to enjoy both your meal and an engaging conversation.
LATAM Pharmacovigilance Inspections: Emerging Trends, Regional Challenges, and Future Expectations for the Pharmaceutical Industry hosted by Josefina Mendoza, Grünenthal LATAM
Pharmacovigilance inspections across Latin America are becoming increasingly complex as health authorities strengthen their focus on compliance, quality systems, digital tools, and patient safety. This interactive roundtable will bring together regulators and industry experts to discuss emerging inspection trends, common findings, regional challenges, and practical strategies for inspection readiness, while exploring opportunities for greater collaboration across the region.
Regulatory Collaboration, Convergence and Harmonization for Post-Approval Changes: Leveraging European Reforms to Enhance LATAM Agility hosted by Maria Antonieta Roman, Novartis
Recent reforms in Europe are reshaping the way post-approval changes are managed, creating new opportunities to strengthen regulatory efficiency, collaboration, reliance, convergence, and harmonization across regions. This interactive roundtable will explore how Latin American regulatory authorities and industry stakeholders can leverage these developments to accelerate the implementation of science- and risk-based approaches for lifecycle management. Participants will discuss opportunities, challenges, and practical pathways to enhance regulatory agility, reduce unnecessary complexity, and support more timely patient access to medicines through greater international alignment.
Patient Voices, Regulatory Power, Advocacy in Latin America hosted by Sara Tylosky, Farmacon Global and Carlos Martinez, Independent Consultant
This lunch roundtable brings together a small group for an informal discussion on how patient advocacy groups can most effectively influence regulatory decision-making across Latin America. We will explore the practical challenges advocacy groups face in influencing decisions before they are finalized, the opportunities available to strengthen their voice, and what regulators look for when engaging with these groups. Limited to ten participants to allow for candid, direct conversation.
Have an account?